YudkinJS, KumariM, HumphriesSE, Mohamed-AliV.Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?. Atherosclerosis, 2000; 148:209–214.
2.
SarvottamK, MaganD, YadavRK, et al.Adiponectin, interleukin-6 and cardiovascular disease risk factors are modified by a short-term yoga-based lifestyle intervention in overweight/obese male subjects. J Altern Complement Med, 2013; 19:397–402.
3.
Al-DaghriNM, Al-AttasOS, AlokailMS, et al.Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest, 2013; 43:183–189.
4.
ShibataR, OuchiN, MuroharaT.Adiponectin and cardiovascular disease. Circ J, 2009; 3:608–614.
5.
UkkolaO, SantaniemiM.Adiponectin: A link between excess adiposity and associated comorbidities?. J Mol Med (Berl), 2002; 80:696–702.
6.
StefanN, StumvollM.Adiponectin—Its role in metabolism and beyond. Horm Metab Res, 2002; 34:469–474.
7.
BauneBT, RothermundtM, LadwigKH, et al.Systemic inflammation (interleukin 6) predicts all-cause mortality in men: Results from a 9-year follow-up of the MEMO Study. Age (Dordr), 2011; 33:209–217.
